Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C (2021)

First Author: Cooke G

Attributed to: Stratified Medicine to Optimise Treatment for Hepatitis C Virus Infection funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1101/2021.01.22.21250208

Publication URI: http://dx.doi.org/10.1101/2021.01.22.21250208

Type: Preprint